20-F/A

AMENDMENT NO. 1

Company: Biodexa Pharmaceuticals Plc
Filed: June 17, 2020
Period of Report: December 31, 2019
Accession Number: 0001214659-20-005715

View Document ↗ View on SEC.gov ↗